These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10885902)

  • 1. Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin.
    Dempke W; Voigt W; Grothey A; Schmoll HJ
    Anticancer Drugs; 1999 Jul; 10(6):545-9. PubMed ID: 10885902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
    Li L; Keating MJ; Plunkett W; Yang LY
    Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY; Ali-Osman F
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair capacity and cisplatin sensitivity of human testis tumour cells.
    Köberle B; Grimaldi KA; Sunters A; Hartley JA; Kelland LR; Masters JR
    Int J Cancer; 1997 Mar; 70(5):551-5. PubMed ID: 9052754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin resistance and oncogenes--a review.
    Dempke W; Voigt W; Grothey A; Hill BT; Schmoll HJ
    Anticancer Drugs; 2000 Apr; 11(4):225-36. PubMed ID: 10898536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer.
    Feng Z; Hu W; Chen JX; Pao A; Li H; Rom W; Hung MC; Tang MS
    J Natl Cancer Inst; 2002 Oct; 94(20):1527-36. PubMed ID: 12381705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring gene-specific nucleotide excision repair in human cells using quantitative amplification of long targets from nanogram quantities of DNA.
    Van Houten B; Cheng S; Chen Y
    Mutat Res; 2000 Jul; 460(2):81-94. PubMed ID: 10882849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated ras oncogene and specifically acquired resistance to cisplatin in human mammary epithelial cells: induction of DNA cross-links and their repair.
    Levy E; Baroche C; Barret JM; Alapetite C; Salles B; Averbeck D; Moustacchi E
    Carcinogenesis; 1994 May; 15(5):845-50. PubMed ID: 8200085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.
    Shen YH; Chen BR; Cherng SH; Chueh PJ; Tan X; Lin YW; Lin JC; Chuang SM
    Toxicol Lett; 2011 Sep; 205(3):341-50. PubMed ID: 21742020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay.
    Kalinowski DP; Illenye S; Van Houten B
    Nucleic Acids Res; 1992 Jul; 20(13):3485-94. PubMed ID: 1630919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
    Chao CC
    Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 2-chloro-2'-deoxyadenosine incorporation into cellular DNA by quantitative polymerase chain reaction.
    Yuh SH; Tibudan M; Hentosh P
    Anal Biochem; 1998 Aug; 262(1):1-8. PubMed ID: 9735141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA.
    Dixit M; Yang JL; Poirier MC; Price JO; Andrews PA; Arteaga CL
    J Natl Cancer Inst; 1997 Mar; 89(5):365-73. PubMed ID: 9060958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.
    Mukai M; Kanzaki A; Chen ZS; Miyashita H; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Takamatsu H; Akiyama S
    Oncol Rep; 2002; 9(4):839-44. PubMed ID: 12066219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
    Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
    J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    Yang LY; Li L; Keating MJ; Plunkett W
    Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
    Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
    Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair in cisplatin-sensitive and resistant human cell lines measured in specific genes by quantitative polymerase chain reaction.
    Köberle B; Payne J; Grimaldi KA; Hartley JA; Masters JR
    Biochem Pharmacol; 1996 Dec; 52(11):1729-34. PubMed ID: 8986135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.